Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

232.36 +0.07 (+0.03%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
89 90 Next >
News headline image
10 One Decision Stocks To Buy Now ↗
The following 10 one decision stocks have increased their dividends for over 25 years, making them Dividend Aristocrats. 
Via Talk Markets
Topics Stocks / Equities
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
2 Brilliant Dividend Growth Stocks That Can Supercharge Your Portfolio ↗
Via The Motley Fool
News headline image
3 High-Yielding Dividend Stocks That Could Be Ideal Investments for Retirees ↗
Via The Motley Fool
News headline image
Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal ↗
Johnson & Johnson's $14.6 billion acquisition of Intra-Cellular Therapies boosts its CNS portfolio with Caplyta and a promising clinical-stage pipeline. 
Via Benzinga
News headline image
AbbVie Unusual Options Activity For January 10 ↗
 
Via Benzinga
News headline image
Assessing AbbVie: Insights From 17 Financial Analysts ↗
 
Via Benzinga
News headline image
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
3 High-Yield Dividend Stocks to Buy in 2025 ↗
Via The Motley Fool
News headline image
3 Incredible Dividend Stocks to Buy in 2025 ↗
These wildly successful companies are poised to keep your dividend portfolio healthy in 2025 and beyond. 
Via The Motley Fool
News headline image
8 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
The Smartest Dividend Stocks to Buy With $500 Right Now ↗
Some prominent healthcare and consumer stocks have fallen out of favor with the market, so now is the time to pounce on some great deals. 
Via The Motley Fool
News headline image
25 Top Dividend Stocks to Buy and Hold in 2025 ↗
Via The Motley Fool
News headline image
Looking Into AbbVie's Recent Short Interest ↗
 
Via Benzinga
News headline image
$100 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Is AbbVie Stock a Buy? ↗
Via The Motley Fool
News headline image
2 No-Brainer Dividend Stocks to Buy With $250 in 2025 ↗
Via The Motley Fool
News headline image
Time to Dump or Double Up on SCHD? ↗
SCHD shares have fallen nearly 10% in a month. 
Via The Motley Fool
News headline image
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade ↗
Via The Motley Fool
News headline image
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields ↗
 
Via Benzinga
News headline image
Healthcare And Biotech Stocks Continue Their Slide ↗
Biotech shares continued their slide which began in early November and got no help from small caps which also sold off through December. 
Via Talk Markets
Topics ETFs Stocks / Equities
News headline image
Stocks Going Ex Dividend In January 2025 ↗
The following is a short list of some of the many stocks going ex-dividend during the next month. 
Via Talk Markets
Topics Stocks / Equities
News headline image
2 Excellent Dividend Stocks to Buy on the Dip ↗
Via The Motley Fool
News headline image
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NASDAQ:AZN),(NYSE:ABBV),(NASDAQ:CRDF) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
The Smartest Dividend Stocks to Buy With $1,000 Right Now ↗
Via The Motley Fool
News headline image
Introducing the "Dividend Seven" Stocks ↗
Via The Motley Fool
News headline image
Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook
From FN Media Group LLC
Via GlobeNewswire
News headline image
Schwab US Dividend Equity ETF Reverses In December: What's Going On? ↗
The Schwab US Dividend Equity ETF has given back more than half of its one-year gains in the last month, with the ETF falling more than 7% in December. Here's a look at what may be plaguing the fund: 
Via Benzinga
Topics ETFs
News headline image
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More ↗
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb. 
Via Benzinga
News headline image
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗
Via The Motley Fool
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
89 90 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.